Lumos Pharma’s Patient-Centric Strategy for Rare Disease Drug Development
XTalks
JANUARY 23, 2024
Among these, rare pediatric diseases present unique challenges and opportunities for rare disease drug development. Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development. This venture also led me to identify a gap in the market for contract manufacturing of recombinant proteins.
Let's personalize your content